ITEMS IN AFP WITH KEYWORD:
Family Planning and Contraception
Sep 1, 2007 Issue
Advance Provision for Emergency Oral Contraception [Cochrane for Clinicians]
Providing oral emergency contraceptives in advance to fertile women for use after unprotected sexual intercourse (i.e., advance provision) does not affect pregnancy rates, condom use, sexually transmitted infection rates, or type of contraception used. Advance provision more than doubles the odds th...
Guidelines on the use of hormonal contraceptives in women with underlying medical conditions are available from the American College of Obstetricians and Gynecologists (ACOG). In some women, drugs taken for certain chronic conditions may alter the effectiveness of hormonal contraceptives.
Vasectomy remains an important option for contraception. Research findings have clarified many questions regarding patient selection, optimal technique, postsurgical follow-up, and risk of long-term complications. Men who receive vasectomies tend to be non-Hispanic whites, well educated, married or ...
Nov 15, 2006 Issue
Noncontraceptive Uses of the Levonorgestrel Intrauterine System [Practice Guidelines]
Although the levonorgestrel-releasing intrauterine system (Mirena) is approved for contraception, it also may have noncontraceptive uses, such as treating idiopathic menorrhagia. The American College of Obstetricians and Gynecologists (ACOG) published a committee opinion to address the noncontraceptive uses of this system.
Most women can safely begin taking hormonal birth control products immediately after an office visit, at any point in the menstrual cycle. Because hormonal contraceptives do not accelerate cervical neoplasia or interfere with cervical cytology, women who have not had a recent Papanicolaou smear can ...
The levonorgestrel-releasing intrauterine system is a reliable, reversible, low-maintenance method of long-term contraception. Rates of failure are similar to those of female sterilization, and the risk of expulsion is minimal for most users.
Mar 1, 2006 Issue
Cyclic vs. Continuous or Extended- Cycle Combined Contraceptives [Cochrane for Clinicians]
Evidence shows no difference in safety or effectiveness between cyclic and continuous or extended-cycle combined contraceptives. There are fewer menstrual symptoms with extended-cycle contraceptives. Patients’ satisfaction and adherence is similar for all types.
The American Academy of Pediatrics (AAP) recommends that education and counseling about emergency contraception be incorporated into the annual preventive visits of adolescent patients when issues of sexuality are addressed.
Although no difference in effectiveness has been demonstrated in existing trials, too few patients have been studied to detect small but clinically important differences in pregnancy rates. Low-dose estrogen pills have higher rates of discontinuation and bleeding disturbances.
Women using ethinyl estradiol/levonorgestrel can expect similar or improved effectiveness and fewer menstrual cycles. Due in part to an increased incidence of unexpected bleeding in the first six months of use, a greater percentage of women will discontinue this regimen than will those using standard oral contraceptives.